Dr. Ma'En Nayef Al-Dabbas, MD

Dr. Al-Dabbas practices at Hannibal Regional Hospital in Hannibal, Missouri, part of Hannibal Regional Healthcare System.

Dr. Al-Dabbas' NPI, 1487032421, was assigned on May 11, 2015. Dr. Al-Dabbas holds Missouri license 2021045042.

Dr. Al-Dabbas' primary practice is Hannibal Regional Hospital, at 6000 Hospital Dr, Hannibal, MO 63401 in Marion County. The practice phone is (573) 248-1300.

Dr. Al-Dabbas' primary practice is Hannibal Regional Hospital in Hannibal, Missouri, part of Hannibal Regional Healthcare System. Dr. Al-Dabbas is also affiliated with Barnes-Jewish Hospital. The medical group on file is Hannibal Regional Medical Group. Dmand AI also links Dr. Al-Dabbas to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Dabbas practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Al-Dabbas' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Al-Dabbas' licenses on file in 2 states: Missouri and New York.

CMS data shows 1,834 Medicare services from Dr. Al-Dabbas across 16 procedure codes in 2024, for 762 Medicare patients. Medicare paid $77,850 for them.

CMS counts 762 Medicare patients who saw Dr. Al-Dabbas in 2024. The largest group is 75 to 84, with 277 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al-Dabbas' median patient age at 73, with 58% women.

In 2024, Dr. Al-Dabbas wrote 1,382 Medicare Part D claims for 179 patients. 85% of them were for generic drugs. CMS names the drug for 1,310 of them, across 23 drugs with 11 or more claims each, at $131,368 in total drug cost. In 2023, CMS named 1,059 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Al-Dabbas for performance year 2024, reported as part of a group. Dr. Al-Dabbas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of coronary angioplasty and stenting by Dr. Al-Dabbas, more than 58% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Al-Dabbas in 2022. 2022 was the busiest year, with 4. The most frequent topics are Atrial Fibrillation and Cardiac Catheterization. Dr. Al-Dabbas has published most often in Cardiovasc Revasc Med. Dr. Al-Dabbas' most frequent co-authors are Amir M. Khan, MD, Mohammed Taleb, MD and Sinan Alo, DO.

CMS Open Payments shows 169 general payments to Dr. Al-Dabbas from 33 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 96% of the total. Medtronic, Inc. paid the most, $866.